MedTrace Logo

Evaluation of Antibody Tests for COVID-19

NCT04360954 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 461

Last updated 2024-06-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the sensitivity and specificity of several marketed commercial or prototype test kits for antibody to SARS-CoV-2. The focus will be on rapid-format, point-of-care antibody test kits that detect both IgM and IgG antibodies to recombinant viral proteins.

Note: No voluntary enrolment into this study will be conducted; all testing is to be conducted anonymously.

Conditions

Interventions

DIAGNOSTIC_TEST

Diagnostic test

There is no intervention. This study will test deidentified archived biosamples.

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-23
Primary Completion
2020-07-08
Completion
2020-07-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04360954 on ClinicalTrials.gov